Innate Pharma is added to the list, becoming the fourth healthcare stock in the list for 4Q

Healthcare: Sector View
News published on October Wednesday 7, 2015
Share on

We see a lot of opportunities in the Large Cap Pharma universe in 4Q, including with cheap Sanofi and GSK if they are successful with their respective Investor Days. However, we will keep Roche for the quarter as ECTRIMS and the Pharma Day should translate into potential upgrades and good momentum.


To get the full report, please contact marketing@bryangarnier.com 

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities